Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05915299 · ClinicalTrials.gov registry record
US National OCS Heart Perfusion (OHP) Registry
A clinical trial of Heart Transplant, sponsored by TransMedics.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 20
- Study locations
NCT05915299 is a study of Heart Transplant that is actively recruiting participants, run by TransMedics. The registered enrollment target is 100,000 participants, above the 197-participant average among 12 other Heart Transplant trials with a reported enrollment target (50661% higher). The trial reports 20 study locations across 11 states.
The verdict
NCT05915299, a study of Heart Transplant, is actively recruiting participants, sponsored by TransMedics.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
This Registry is a sponsor initiated, multi-center, observational post-approval registry with independent academic oversight.
Conditions Studied
Interventions
- DEVICE OCS Heart
Study Locations (20)
California
- University of California San Diego - La Jolla
- Lucile Packard Children's Hospital Stanford - Palo Alto
- Stanford University - Palo Alto
- University of California San Francisco - San Francisco
Massachusetts
- Tufts Medical Center - Boston
- Massachusetts General Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Minnesota
- Minneapolis Heart Institute - Minneapolis
- University of Minnesota - Minneapolis
- Mayo Clinic Rochester - Rochester
Florida
- Mayo Clinic Florida - Jacksonville
- Tampa General Hospital - Tampa
Michigan
- University of Michigan - Ann Arbor
- Henry Ford - Detroit
Arizona
- Banner University Medical Center Phoenix - Phoenix
Colorado
- Boulder - Boulder
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2023-08-25 |
| Est. Completion | 2033-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05915299
The ClinicalTrials.gov registry entry for NCT05915299 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 197-participant average among 12 other Heart Transplant trials with a reported enrollment target (50661% higher). The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Transplant appearing as the primary indexed condition, and to 1 intervention - of which OCS Heart is the first listed.
NCT05915299 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Massachusetts, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05915299 about?
NCT05915299 is a clinical study titled "US National OCS Heart Perfusion (OHP) Registry". This Registry is a sponsor initiated, multi-center, observational post-approval registry with independent academic oversight.
What is the current status of trial NCT05915299?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2023-08-25. Estimated completion is 2033-08-31.
What conditions does trial NCT05915299 study?
This clinical trial studies the following conditions: Heart Transplant.
What interventions are being tested in trial NCT05915299?
The interventions under investigation include: OCS Heart (DEVICE).
Who is sponsoring clinical trial NCT05915299?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05915299 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
RECRUITING · NA
-
Belatacept in Heart Transplantation
RECRUITING · Phase 2
-
Enhancing Heart Allograft Function With the OCS Heart System Trial
RECRUITING · NA
-
Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
RECRUITING
-
Randomized Trial of SGLT2i in Heart Transplant Recipients
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.